Recent Press Releases

In Interim Results from Phase 3 Study, Merck's Investigational Ebola Vaccine Efficacious; Study is Continuing

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (known as MSD outside the US and Canada) said today that its investigational Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100 percent efficacy in...

Kailos Genetics Hires Cheri Walker As Chief Financial Officer

Walker to support corporate strategic development following the launch of Praxis, a consumer-directed gene-based test HUNTSVILLE, Ala.--(BUSINESS WIRE)--Kailos Genetics, a personalized medicine...

Otic Pharma Appoints Gregory J. Flesher As Chief Executive Officer

IRVINE, Calif. and REHOVOT, Israel, July 27, 2015 /PRNewswire/ -- Otic Pharma Ltd, a privately held pharmaceutical company focused on developing innovative therapies for ear, nose, and throat...

CTI BioPharma Appoints Bruce J. Seeley As Executive Vice President And Chief Commercial Officer

SEATTLE, July 27, 2015 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the appointment of Bruce J. Seeley as Executive Vice President and Chief Commercial...

Heat Biologics Announces Promotions Of Taylor Schreiber, M.D., Ph.D., To Chief Scientific Officer, And Melissa Price, Ph.D., To Vice President Of Product Development

DURHAM, N.C., July 27, 2015 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat" or the "Company") (NASDAQ:HTBX), a clinical stage biopharmaceutical company focused on the...

Keryx (KERX) Appoints Scott A. Holmes As Chief Financial Officer

BOSTON, July 27, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the appointment of Scott A. Holmes to Chief Financial Officer effective immediately. Mr. Holmes...

GlySure Appoints Roger Moody As Chief Executive Officer

ABINGDON, England--(BUSINESS WIRE)--GlySure Limited, a leader in continuous glucose monitoring for critical care patients, today announced the appointment of Roger Moody as Chief Executive Officer....

Vitae Pharma (VTAE) Appoints Dr. John M. Leonard To Board Of Directors

FORT WASHINGTON, Pa., July 29, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), a clinical-stage biotechnology company, today announced the appointment of John M. Leonard, M.D., to...

Enzymotec Announces The Appointment Of Tamar Howson To Its Board Of Directors

MIGDAL HA'EMEQ, Israel, July 30, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...

ChemoCentryx, Inc. (CCXI) Announces Changes To Its Board Of Directors

MOUNTAIN VIEW, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and...

Loxo Oncology (LOXO) Appoints Industry Veteran Tim Mayleben To Board Of Directors

STAMFORD, Conn., July 30, 2015 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company focused on the discovery, development, and commercialization of targeted cancer...

BioAmber Inc. Announces Change In Chief Financial Officer

MONTREAL, July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) today announced that Francois Laurin, the Company's Chief Financial Officer has resigned. The Company has hired Andrew Ashworth, its...

TapImmune Inc. (TPIV) Appoints John N. Bonfiglio, Ph.D., To Its Board Of Directors

SEATTLE, July 30, 2015 /PRNewswire/ -- TapImmune Inc. (OTCMKTS: TPIV) is pleased to announce the appointment of John N. Bonfiglio, Ph.D., MBA to its Board of Directors. Since February, 2015 Dr....

Easton Pharmaceuticals (OP: EAPH) Announces The Appointment Of Evan Karras As CEO / Director And Mr. Nunzio Valerie As President

TORONTO, ON--(Marketwired - Jul 29, 2015) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces the appointment of Evan Karras as CEO & Director and announces Mr. Nunzio Valerie as President...

Nymox Pharmaceutical (NYMX) Announces Appointment Of James G. Robinson To Board Of Directors

HASBROUCK HEIGHTS, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that the Company has newly appointed James G. Robinson to the Board of...

Unum Names Geoffrey Hodge As Senior Vice President, Operations

- Co-Founder of Xcellerex and Former Operations Leader at GE Healthcare Life Sciences to Lead Unum's Clinical Manufacturing and Process Development Activities - CAMBRIDGE, Mass.--(BUSINESS...

Cytori Therapeutics, Inc. (CYTX) Appoints VP Of Business Development And General Counsel

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that Mr. Jeremy Hayden has been appointed as General Counsel and VP of Business Development. In addition to...

Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer

NEW YORK, July 29, 2015 /PRNewswire/ -- Turing Pharmaceuticals AG announced today that Craig A. Rothenberg has joined the company as its first Chief Communication Officer. In this new role, Mr....

Pamela J. Craig And Dr. Paul B. Rothman Elected To Merck & Co. (MRK) Board Of Directors

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Pamela J. Craig, retired chief financial officer of Accenture, and Dr....

Catalent, Inc. Appoints J. Martin Carroll To Its Board Of Directors

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health...